Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Fat stem cells from diabetic mice can still help heal wounds.

Different drug doses approved in Japan and the U.S. are not mainly due to different clinical responses, and ethnic factors should be considered in setting drug doses.

Activating TRPA1 reduces scarring and promotes tissue regeneration.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

A patch made from human lung fibroblast material helps heal skin wounds effectively, including diabetic ulcers.

The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.

Effective PCOS treatments require targeting specific signaling pathways.

Removing REDD1 in mice increases skin fat by making fat cells larger and more numerous.

New vitamin D3 forms need the vitamin D receptor to reduce fibrosis in human cells.

BRG1 is essential for skin cells to move and heal wounds properly.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

Insulin resistance increases the risk of developing type 2 diabetes and other health issues.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Proper skin care and dermocosmetics improve skin issues in diabetes patients.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Marine algae compounds may improve skin health and promote hair growth.

New research shows that skin diversity is influenced by different types of dermal fibroblasts and their development, especially involving the Wnt/β-catenin pathway.

MicroRNAs could be key biomarkers and therapeutic targets for PCOS.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

Enzymes are classified into six types and are essential for many biological processes, with only a few targeted by drugs.

Scientists have improved 3D models of human skin for research and medical uses, but still face challenges in perfectly replicating real skin.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Testosterone's effects on COVID-19 are unclear and need more research.

Topical immunotherapy can treat alopecia areata, but its effectiveness varies and the exact mechanism is unclear.